Literature DB >> 20395370

Bone mass and microarchitecture in CKD patients with fracture.

Thomas L Nickolas1, Emily Stein, Adi Cohen, Valerie Thomas, Ronald B Staron, Donald J McMahon, Mary B Leonard, Elizabeth Shane.   

Abstract

Patients with predialysis chronic kidney disease (CKD) have increased risk for fracture, but the structural mechanisms underlying this increased skeletal fragility are unknown. We measured areal bone mineral density (aBMD) by dual-energy x-ray absorptiometry at the spine, hip, and radius, and we measured volumetric BMD (vBMD), geometry, and microarchitecture by high-resolution peripheral quantitative computed tomography (HR-pQCT) at the radius and tibia in patients with CKD: 32 with fracture and 59 without fracture. Patients with fracture had lower aBMD at the spine, total hip, femoral neck, and the ultradistal radius, the last having the strongest association with fracture. By HR-pQCT of the radius, patients with fracture had lower cortical area and thickness, total and trabecular vBMD, and trabecular number and greater trabecular separation and network heterogeneity. At the tibia, patients with fracture had significantly lower cortical area, thickness, and total and cortical density. Total vBMD at both radius and tibia most strongly associated with fracture. By receiver operator characteristic curve analysis, patients with longer duration of CKD had area under the curve of >0.75 for aBMD at both hip sites and the ultradistal radius, vBMD and geometry at the radius and tibia, and microarchitecture at the tibia. In summary, patients with predialysis CKD and fractures have lower aBMD by dual-energy x-ray absorptiometry and lower vBMD, thinner cortices, and trabecular loss by HR-pQCT. These density and structural differences may underlie the increased susceptibility to fracture among patients with CKD.

Entities:  

Mesh:

Year:  2010        PMID: 20395370      PMCID: PMC2938588          DOI: 10.1681/ASN.2009121208

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  49 in total

1.  Comparison of structure extraction methods for in vivo trabecular bone measurements.

Authors:  A Laib; P Rüegsegger
Journal:  Comput Med Imaging Graph       Date:  1999 Mar-Apr       Impact factor: 4.790

2.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

3.  Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial.

Authors:  Sophie A Jamal; Douglas C Bauer; Kristine E Ensrud; Jane A Cauley; Marc Hochberg; Areef Ishani; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2007-04       Impact factor: 6.741

4.  Increased risk of hip fracture among patients with end-stage renal disease.

Authors:  A M Alem; D J Sherrard; D L Gillen; N S Weiss; S A Beresford; S R Heckbert; C Wong; C Stehman-Breen
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

5.  Relationship between moderate to severe kidney disease and hip fracture in the United States.

Authors:  Thomas L Nickolas; Donald J McMahon; Elizabeth Shane
Journal:  J Am Soc Nephrol       Date:  2006-09-27       Impact factor: 10.121

6.  Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group.

Authors:  S R Cummings; D M Black; M C Nevitt; W Browner; J Cauley; K Ensrud; H K Genant; L Palermo; J Scott; T M Vogt
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

7.  Treatment with alfacalcidol in elderly people significantly decreases the high risk of falls associated with a low creatinine clearance of <65 ml/min.

Authors:  Laurent Dukas; Erich Schacht; Ze'ev Mazor; Hannes B Stähelin
Journal:  Osteoporos Int       Date:  2004-06-17       Impact factor: 4.507

8.  Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure.

Authors:  N A Hamdy; J A Kanis; M N Beneton; C B Brown; J R Juttmann; J G Jordans; S Josse; A Meyrier; R L Lins; I T Fairey
Journal:  BMJ       Date:  1995-02-11

9.  Axial and appendicular bone density predict fractures in older women.

Authors:  D M Black; S R Cummings; H K Genant; M C Nevitt; L Palermo; W Browner
Journal:  J Bone Miner Res       Date:  1992-06       Impact factor: 6.741

10.  Effect of voxel size on 3D micro-CT analysis of cortical bone porosity.

Authors:  David Cooper; Andrei Turinsky; Christoph Sensen; Benedikt Hallgrimsson
Journal:  Calcif Tissue Int       Date:  2007-03-05       Impact factor: 4.333

View more
  65 in total

Review 1.  Mineral and Bone Disease in Kidney Transplant Recipients.

Authors:  Ariella M Altman; Stuart M Sprague
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

2.  Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis.

Authors:  A-J Chang; Q Ying; X-N Chen; W-M Wang; N Chen
Journal:  Osteoporos Int       Date:  2016-07-08       Impact factor: 4.507

Review 3.  Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics.

Authors:  Erin M B McNerny; Thomas L Nickolas
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

4.  Bone microarchitecture in hemodialysis patients assessed by HR-pQCT.

Authors:  Daniel Cejka; Janina M Patsch; Michael Weber; Danielle Diarra; Markus Riegersperger; Zeljko Kikic; Christian Krestan; Claudia Schueller-Weidekamm; Franz Kainberger; Martin Haas
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

5.  The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.

Authors:  J Aleksova; S Kurniawan; G J Elder
Journal:  Osteoporos Int       Date:  2018-03-19       Impact factor: 4.507

6.  Time course of rapid bone loss and cortical porosity formation observed by longitudinal μCT in a rat model of CKD.

Authors:  Erin M B McNerny; Dorothy T Buening; Mohammad W Aref; Neal X Chen; Sharon M Moe; Matthew R Allen
Journal:  Bone       Date:  2019-05-03       Impact factor: 4.398

7.  Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?

Authors:  S Pelletier; C B Confavreux; J Haesebaert; F Guebre-Egziabher; J Bacchetta; M-C Carlier; L Chardon; M Laville; R Chapurlat; G M London; M-H Lafage-Proust; D Fouque
Journal:  Osteoporos Int       Date:  2015-04-25       Impact factor: 4.507

8.  Rapid cortical bone loss in patients with chronic kidney disease.

Authors:  Thomas L Nickolas; Emily M Stein; Elzbieta Dworakowski; Kyle K Nishiyama; Mafo Komandah-Kosseh; Chiyuan A Zhang; Donald J McMahon; Xiaowei S Liu; Stephanie Boutroy; Serge Cremers; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

Review 9.  Updates in CKD-Associated Osteoporosis.

Authors:  Pascale Khairallah; Thomas L Nickolas
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

Review 10.  The use of bone mineral density measured by dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed microtomography in chronic kidney disease.

Authors:  Martin Jannot; Fabrice Mac-Way; Vanessa Lapierre; Marie-Helene Lafage-Proust
Journal:  J Nephrol       Date:  2017-09-12       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.